Yun-ye Liu

Long‐term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B

Xia-qiu Zhou, Q. Xie, Lan-yi Lin, 2015, Journal of gastroenterology and hepatology.

AL amyloidosis with primary presentation of multiple serous cavity effusion and severe cholestasis: a case report and review of literature

Hong Wang, Mingyang Feng, Kehui Liu, 2022, BMC Gastroenterology.

Hepatitis C virus core antigen, an earlier and stronger predictor on sustained virological response in patients with genotype 1 HCV infection

Lai Wei, Yi Kang, J. Shang, 2014, BMC Gastroenterology.

Combination of IL-34 and AFP improves the diagnostic value during the development of HBV related hepatocellular carcinoma

Kehui Liu, Yezhou Ding, S. Bao, 2021, Clinical and Experimental Medicine.

A five years study of antiviral effect of entecavir in Chinese chronic hepatitis B patients

Jingdong Xie, Q. Xie, Kehui Liu, 2016, Scientific Reports.

Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high risk

S. Bao, Q. Xie, Q. Guo, 2018, Expert opinion on biological therapy.

Algorithm of Golgi protein 73 and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infection

Q. Xie, Gang-de Zhao, S. Bao, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Interleukin-34 is associated with hepatocellular carcinoma in chronic hepatitis B patients

Kehui Liu, Yezhou Ding, S. Bao, 2020 .